A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.  Claims of lawsuits against Ozempic and similar drugs are indeed true.

According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a 44-year-old woman from Louisiana who suffered severe vomiting after taking Ozempic and Mounjaro.

In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not for nothing — a lot of people turned to this diabetes medicine with the hopes that it would help them lose weight — and it did.

Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish pharmaceutical company has enacted a hiring freeze—the latest sign of a sinking financial outlook for the once-titan of the obesity treatment world.

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don’t go through insurance.

Christina Aguilera is thrilling fans in her sheer underwear and high heels, but the Ozempic comments are out of control.

The weight loss drug, which was previously also used to treat diabetes, may be having an unexpected impact on a rather sensitive body part

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for more than 3 years. It is one of the most well studied compounds”, says Dr Shashank R Joshi, a Mumbai based endocrinologist and medical researcher.